QA Regulatory forum: Classification and Risk assessment according to MDR Date : T h e r e s e. A l b i n s s o m e d q t e c h.
|
|
- Cleopatra Norris
- 5 years ago
- Views:
Transcription
1 QA Regulatory forum: Classification and Risk assessment according to MDR Date : THERESE ALBINSSON T h e r e s e. A l b i n s s o m e d q t e c h. s e
2 MedQtech AB MedQtech AB is a consultant business within the medical device industry. We support and help our customers in the fields of quality and regulatory compliance. My background: Over 15 years within Medical Device Industry Support in ISO Certification, Support in Medical Device CE-marketing process Regulatory strategy support Compliance MDD/MDR IVDD/IVDR Facilitation of Risk Management, ISO 14971, Internal audits, supplier audits
3 IVDR In vitro Diagnostics Classification and risk based rules
4 Risk based rules IVD IVDR Annex II list A Class D R I S K Annex II list B Class C Class B R I S K Other Class A
5 Ref. MDR & IVDR EU Conference 2017
6 Article 47 Classification of devices Devices shall be divided into classes A, B, C and D, taking into account the intended purpose of the devices and their inherent risks. Class A, Low individual risk and low risk to public health Class B, Moderate individual risk and/or low risk to public health Class A Self-certify ( if sterile IVDs need assessment by NB) Ref. IVDR, Article 48 Class C, High individual risk and/or medium risk for public health Class D, High individual risk and high risk for public health Class C & D Require Quality Management System surveillance of Notified body Ref. IVDR, Article 48, Annex IX Class B, C & D EU technical documentation assessment certificate by Notified Body Ref. IVDR, Article 48, Annex IX
7 IVDR - ANNEX VIII Classification Rules Rule 1 Rule 2 Rule 3 Rule 4 Rule 5 Rule 6 Rule 7 Blood screening High risk diseases Blood grouping High risk dissades Infection diseases Cancer testing Companion diagnostics Geneteic testing. Self testing High risk near patient test Blood gases Blood glucose General laboratory use Non-critical accessories Buffer solutions Instruments None of the other rulse Unassayed conrols High risk blood groups Self test for non-critical conditions Class D Class C Class D Class C Class C Class B Class A Class B Class B
8 Class A May self-certify, but Class A sterile IVDs require an assessment by the NB of the sterile aspects according to Annex IX (or Annex XI). Class B Require quality systems (Annex IX except Chapter II) NBs sampling at least one technical file per generic device group as part of on-site audits unless these devices are self-testing or near-patient testing, in which case the technical documentation of all devices need to be assessed. Class C Require either a full quality management system combined with a review of the technical documentation of at least one device per generic device group (Annex IX except Chapter II), or an EC type-examination (Annex X) together with production quality assurance or EC verification (Annex XI). Class D Requires the same procedure as Class C, plus batch verification and reference laboratory involvement (Annex IX). (Alternatively Annex X and Annex XI certification is possible.) Ref. IVDR, article 48,
9 MDR Medical Device Regulations Classification and risk based rules
10 Article 51 - Classification of Device Devices shall be divided into Classes I (Is, Im, Ir), IIa, IIb and III taking into account the intended purpose of the devices and their inherent risks. Classification shall be carried out in accordance with Annex VIII. Class IIa Class IIb Class III Class Is, Im, Ir Partly Notified body Registered to competent authority Class I, Self-certify, register to competent authority Require Notified Body Review of technical documentation Audit of Quality Management System
11 ANNEX VIII Classification Rules MDR -> 22 rules Rules 1-4: Non-invasive devices Rules 5-8: Invasie devices Rules 9-13 : Active Devices Ruleas : Special rules MDD -> 18 rules Rules 1-4: Non-invasive devices Rules 5-8: Invasie devices Rules 9-12 : Active Devices Ruleas : Special rules 5 new rules, some changes in existing rules and new class Ir, one rules in MDD has been dissmissed (rule 18)
12 MDR - ANNEX VIII Classification Rules Rule 3 Rule 4 Rule 8 Rule 18 Rule 20 Rule 22 All non-invasive devices consisting of a substance or a mixture of substances intended to be used in vitro in direct contact with human cells, tissues or organs taken from the human body or used in vitro with human embryos before their implantation or administration into the body are classified as class III. This rule applies also to the invasive devices that come into contact with injured mucous membrane. Rule 6 Reusable surgical instruments in Class I, But a new classification, Class Ir, applies Added exemption of implantable devices to be classified as class III Rule 11 New rule for classification of software. Class I, IIa, IIb, III State that nonviable tissue of human or animal cells will be considered Class III. Rule 19 New classifies nanomaterials depending on their potential for internal exposure. Class IIa, class IIb, Class III New Places devices intended for inhalation of medicinal substances in risk Classes IIa or IIb. Rule 21 New places devices composed of substances absorbed or dispersed in different classes based on their level of internal exposure. New places active therapeutic devices with an integrated diagnostic function, which provides data on patient management Class III
13 What to do??? Intended use Re-classify your product under the new IVDR/MDR Create a Classification document. Explain the rules/rationales and the class for your device Set your Regulatory Strategy based on the class of the product.
The New Regulations - Special IVD Issues
The New Regulations - Special IVD Issues Dirk Stynen, Ph. D. President - Principal Consultant Qarad Geel, Belgium RMD Brussels October 2018 The IVD Regulation 2017/746 October 29, 2018 www.qarad.com 2
More informationKEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE
RNI Conseil 2017 Tous droits réservés Toute reproduction interdite sans l'autorisation de l'auteur. KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE Anne Laure TARDY, PhD
More informationClassification & Clinical Evidence under the IVDR
Requirements of the IVDR Improving performance, reducing risk Proposed classification rules Annex II to the current IVD Directive addresses the level of risk posed by IVD medical devices by means of a
More informationIntroducing BSI. BSI Medical Device Regulatory Update Galway, Ireland. Dr. Michael Weissig EMEA Vice President Healthcare 26 June, 2015
Introducing BSI BSI Medical Device Regulatory Update Galway, Ireland Dr. Michael Weissig EMEA Vice President Healthcare 26 June, 2015 Copyright 2014 BSI. All rights reserved. Global Healthcare Mission
More informationISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE
ISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE ISO 13485, OVERVIEW ISO 13485 sets regulatory requirements or, when specified, customer requirements for a management system for medical devices or services.
More informationCE-marking of Medical Devices and complete Medical Gas Pipeline Systems (MGPS) Holsterbro Sygehus - Denmark
CE-marking of Medical Devices and complete Medical Gas Pipeline Systems (MGPS) 180827 Holsterbro Sygehus - Denmark Johan Arnfelt Marketing & Bus Dev Mngr, Linde Healthcare EMEA Agenda - My background -
More informationEU Regulatory Requirements Update, the latest news and developments. Hans-Heiner Junker TÜV SÜD Product Service GmbH October 2013
EU Regulatory Requirements Update, the latest news and developments Hans-Heiner Junker TÜV SÜD Product Service GmbH October 2013 Folie 1 Content Two groups of Notified Bodies Designation process with European
More informationMedical - Combined Medical Devices Guideline
Medical - Combined Medical Devices Guideline V 2.0- EFFECTIVE: 1ST OF AUG 2016 Medical - Combined Medical Devices Guideline 1 2 Medical - Combined Medical Devices Guideline Title TABLE OF CONTENTS Definitions
More informationQuality Management System Certification. Understanding Quality Management System (QMS) certification
Quality Management System Certification Understanding Quality Management System (QMS) certification The medical device manufacturing sector is one of the most regulated sectors in which significant quality
More informationa practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210
a practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210 for SMEs a practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210 Copyright protected document All rights reserved.
More informationBILATERAL SCREENING MEETING
Negotiating Group for the Accession of the Republic of Serbia to the European Union - Chapter 28, Consumer and Health Protection BILATERAL SCREENING MEETING Chapter 28 Consumer and Health Protection Brussels,
More informationOn the use of Amalgam for dental fillings in Sweden
On the use of Amalgam for dental fillings in Sweden Director Medical Devices Medical Products Agency Uppsala, Sweden Content of this presentation Short regulatory introduction Current use of Amalgams in
More informationThis document is a preview generated by EVS
TECHNICAL REPORT RAPPORT TECHNIQUE TECHNISCHER BERICHT CEN/TR 17223 March 2018 ICS 03.100.70; 11.040.01 English version Guidance on the relationship between EN ISO 13485: 2016 (Medical devices - Quality
More informationINDEPENDANT CONSULTING FOR QUALITY AND REGULATORY AFFAIRS EXPERTS FOR MEDICAL DEVICES REFERENCES. DATE POSITION ACTIVITIES MEDICAL DEVICES 2009 to NOW
INDEPENDANT CONSULTING FOR QUALITY AND EXPERTS FOR MEDICAL DEVICES REFERENCES OUTSOURCED SERVICES DATE POSITION ACTIVITIES MEDICAL DEVICES 2009 to NOW QUALITY AND MANAGER company which designs and manufactures
More informationCOMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES
COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental
More informationDRAFT FOR REVIEW. Medicines and Allied Substances Control (Medical Devices) Regulations, 2011 PART I DATABASE OF INFORMATION
Statutory Instrument 2011. DRAFT FOR REVIEW [CAP. 15:03 Medicines and Allied Substances Control (Medical Devices) Regulations, 2011 ARRANGEMENT OF SECTIONS PRELIMINARY Section 1. Title. 2. Interpretation.
More informationIso Audit Checklist
ISO 13485 AUDIT CHECKLIST PDF - Are you looking for iso 13485 audit checklist Books? Now, you will be happy that at this time iso 13485 audit checklist PDF is available at our online library. With our
More informationEC Certificate - Production Quality Assurance Directive 93/42/EEC on Medical Devices, Annex V
Directive 93/42/EEC on Medical Devices, Annex V No. CE 80978 In respect of: The manufacture of sterile cryopresevation devices (Cryopette ) and sterile micropipettes/stripper tips intended for the preparation,
More informationIso Audit Checklist
We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with iso 13485 audit checklist.
More informationAustralian Jurisdictional Update September 2018
Australian Jurisdictional Update September 2018 Dr Elizabeth McGrath Strategic Adviser Medical Devices and Product Quality Division Department of Health Overview The Australian Government s Expert Review
More informationRegulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices
Regulatory Framework for Medical Devices in South Africa 23 November 2018 Andrea Keyter Deputy Director: Medical Devices Medicines and Related Substances Act, 1965 (Act 101 of 1965) Act 72 of 2008 and
More informationQuality Assurance Standard. Implemented 1991 Revised Version 3.0
Implemented 1991 Revised 2006 Version 3.0 IQPP Contents I. Introduction... 3 II. Definitions... 4 III. PPTA Source Quality Assurance Principles... 4 IV. Audits and Compliance Verification... 5 Page 2 IQPP
More informationa practical guide Medical Devices Advice from ISO/TC 210 This is a free 11 page sample. Access the full version online.
NSAI/ISO Guide to ISO 13485:2016 Medical Devices a practical guide Advice from ISO/TC 210 NSAI/ISO Guide to ISO 13485:2016 This Guide is the NSAI adoption of and is technically identical to the English
More informationMedical Devices Act 1
Issuer: Riigikogu Type: act In force from: 01.01.2016 In force until: 31.05.2016 Translation published: 01.02.2016 Medical Devices Act 1 Amended by the following acts Passed 13.10.2004 RT I 2004, 75, 520
More informationGlobal Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488
Page 1 of 6 Global Harmonization Task Force SG3 ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO 13485 and 13488 GENERAL COMMENTS The Global Harmonization Task Force Study Group Three (GHTF
More informationMedical Devices. UKRAINE Magisters
Medical Devices UKRAINE Magisters CONTACT INFORMATION Oleg Boichuk, Senior Associate Oleksandr Liulkov, Associate Magisters 38 Volodymyrska St., Kyiv, Ukraine +38044 492 82 82 www.magisters.com 1. Definition
More informationGUIDE FOR THE NEW ELECTRONIC PAYMENT SYSTEM. Version 1.0 Spanish Agency of Medicines and Medical Devices
GUIDE FOR THE NEW ELECTRONIC PAYMENT SYSTEM Version 1.0 Spanish Agency of Medicines and Medical Devices NEW ELECTRONIC PAYMENT SYSTEM INTRODUCTION AND ENTRY TO THE SYSTEM DEPARTMENT OF MEDICINES FOR HUMAN
More informationKiwa Inspecta. Kiwa Inspecta. Trust Quality Progress
Pressure equipment Third party agency In-Service Inspection Condition controls Crane and Lifting Risk assesments Elevator acts independently with integrity and full respect for the customers needs. As
More informationSingle European Code for Tissues and Cells
Single European Code for Tissues and Cells Mr Richard Forde, Blood Tissues and Organs Inspector Health Products Regulatory Authority 19 th Overview: The Single European Code (SEC): Legislative Basis; Eurocet
More informationWelcome to presentation By Sanjay Punjabi Lead Auditor for ISO 9001, ISO 14001, OHSAS & BS 7799
Welcome to presentation By Sanjay Punjabi Lead Auditor for ISO 9001, ISO 14001, OHSAS 18001 & BS 7799 NETPECKERS CONSULTING (P) LTD. An ISO 9001:2000 compliant organization On Advantages, importance &
More informationQuality Assurance Policy. for the. Procurement of HIV Point-of-Care Technology. under the UNITAID Grant
Quality Assurance Policy for the Procurement of HIV Point-of-Care Technology under the UNITAID Grant UNICEF Supply Division Quality Assurance Centre and Health Technology Centre Revisions Version Date
More informationManufacture of Medical Devices within Healthcare Institutions A GUIDANCE NOTE FROM THE IRISH MEDICINES BOARD
Manufacture of Medical Devices within Healthcare Institutions A GUIDANCE NOTE FROM THE IRISH MEDICINES BOARD PREFACE GUIDANCE NOTE ON THE MANUFACTURING OF MEDICAL DEVICES WITHIN HEALTHCARE INSTITUTIONS
More informationAustralian regulatory guidelines for medical devices
Australian regulatory guidelines for medical devices (ARGMD) Version 1.1, May 2011 Therapeutic Goods Administration About the Therapeutic Goods Administration (TGA) The Therapeutic Goods Administration
More information11. European Union Regulation of In Vitro Diagnostic Medical Devices
11. European Union Regulation of In Vitro Diagnostic Medical Devices By Grant Castle and Robin Blaney I. Introduction This chapter discusses the European Union (EU) regulation of in vitro diagnostic (IVD)
More informationAustralian regulatory guidelines for medical devices
Australian regulatory guidelines for medical devices (ARGMD) Version 1.1, May 2011 Therapeutic Goods Administration About the Therapeutic Goods Administration (TGA) The TGA is a division of the Australian
More informationUpdate on Australian regulatory framework for medical devices
MTAA Update on Australian regulatory framework for medical devices Val Theisz, MSc, RAC Director Regulatory Affairs, MTAA April 2017 Who is MTAA? The Medical Technology Association of Australia (MTAA)
More informationTruGuard Custom Tongue and Jaw Positioner Instructions for Use
TruGuard Custom Tongue and Jaw Positioner Instructions for Use Caution: Federal Law restricts this device to sale by or on the order of a licensed Physician or Radiation Therapist. DEVICE DESCRIPTION Bionix
More informationNotification of a Body in the framework of a technical harmonization directive
Notification of a Body in the framework of a technical harmonization directive From : Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG) Heinrich-Böll-Ring 10 53119
More informationCOMMISSION REGULATION (EU) / of XXX
Ref. Ares(2016)6396619-14/11/2016 EUROPEAN COMMISSION Brussels, XXX SANTE/10539/2016 CIS Rev. 3 (POOL/G4/2016/10539/10539R4-EN CIS.doc) [ ](2016) XXX draft COMMISSION REGULATION (EU) / of XXX amending
More informationZ E R T I F I K AT. Rayonex Biomedical GmbH DIN EN ISO 9001 : 2008
Z E R T I F I K AT für das Managementsystem nach DIN EN ISO 9001 : 2008 Der Nachweis der regelwerkskonformen Anwendung wurde erbracht und wird gemäß TÜV NORD CERT-Verfahren bescheinigt für Rayonex Biomedical
More informationStandard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes
Scope To describe the procedure for EFSA to request on a yearly or ad-hoc basis the performance of GLP studies audits by the GLP Monitoring Authorities. To lay down criteria for the selection of the GLP
More informationDiabetes Management in hospital care: GlucoTab - A medical device to improve insulin treatment of patients with diabetes type 2
Diabetes Management in hospital care: GlucoTab - A medical device to improve insulin treatment of patients with diabetes type 2 JOANNEUM RESEARCH Forschungsgesellschaft mbh HEALTH Institute for Biomedicine
More informationQuality and Excellence
Quality and Excellence What is Accel-Heal? Accel-Heal is a compact (7cm x 4cm x 2cm), certified and patented, battery powered electroceutical treatment device (Class IIA) designed to improve and accelerate
More informationBEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018
BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE Yuan Xu 18- JAN- 2018 Background AGENDA What is Medical Device? What is 510(k)? Principles of best practices of device
More informationLakshy Management Consultant Pvt. Ltd.
What is ISO 13485:2003? You can t buy trust. BUILD IT through ISO 13485. Demonstrate your ability to supply medical devices through Quality Management System for Medical Devices - ISO 13485 ISO 13485 is
More informationAlignment of FSMA with Existing Food Safety Programs International Citrus & Beverage Conference
Alignment of FSMA with Existing Food Safety Programs International Citrus & Beverage Conference Donald Kautter US Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food
More informationMeeting the Quality Challenge for Orally Inhaled Drug Products. Review Impact of Emerging EMA/MHRA Guidelines and Standards
IPAC-RS/RDD 2016 SYMPOSIUM Meeting the Quality Challenge for Orally Inhaled Drug Products Review Impact of Emerging EMA/MHRA Guidelines and Standards Joseph Lim (PhD) Senior Pharmaceutical Assessor (MHRA)
More information(Tentative Translation)
(Tentative Translation) Public Notice of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Ministry of Health, Labour and Welfare (MHLW) No. 2 of December 17, 2010 Table
More informationGOOD REGULATORY REVIEW PRACTICES WORKING GROUP UPDATE. Working Group Chair: Melissa Torres US Food and Drug Administration
GOOD REGULATORY REVIEW PRACTICES WORKING GROUP UPDATE Working Group Chair: Melissa Torres US Food and Drug Administration GOALS The Good Regulatory Review Practices working group has focused efforts on
More informationNCS. Natural Cosmetics Standard
NCS Natural Cosmetics Standard Table of contents INTRODUCTION... 3 SCOPE OF APPLICATION... 3 ASSORTMENT REQUIREMENTS... 3 GENERAL CRITERIA... 4 1. DEFINITION OF PERMITTED RAW MATERIAL GROUPS... 4 2. RAW
More informationSTERILITY TESTING OF PHARMACEUTICAL PRODUCTS
STERILITY TESTING OF PHARMACEUTICAL PRODUCTS Tim Sandle CONTENTS Introduction xiii 1 STERILITY 1 Introduction 1 Sterility 3 Microorganisms and Microbial Growth 5 Types of microorganisms 7 Sterilization
More informationDECLARATION OF CONFORMITY To Council Directive 93/42/EEC of 14 June 1993
DECLARATION OF CONFORMITY To Council Directive 93/42/EEC of 14 June 1993 Manufacturer: EC Authorized Representative: T.A.G. Medical Products Corporation LTD. Kibbutz Gaaton 2513000 Israel Tel: (972) 4
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL ACCESS to and CONTROL of MEDICAL DEVICES and IVDs This guideline is intended to provide recommendations to Manufacturers, Importers, Exporters, Distributors, Wholesalers and Holders
More informationMeeting of the EU GLP Working Group, February GLP requirements in EU legislation and guidance medical devices
Meeting of the EU GLP Working Group, 22-23 February 2017 Agenda item: Document title: Action required: Session 2, item 2a GLP requirements in EU legislation and guidance medical devices Requirements of
More informationEstablishing Rules for: Medical Device Reports (803) & Correction and Removal Reports (806)
Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports (806) Presented by: Cap Uldriks, FDA Daniel P. Olivier, CCS Page 1 Objectives Define regulatory reporting rules based
More informationUPDATE ON THE GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS
UPDATE ON THE GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS DDL2017 6-8 December 2017 Presented by Claudia Vincenzi on 7 December 2017 Quality Office EMA An agency of the European
More informationNotification of a Body in the framework of a technical harmonization directive
Notification of a Body in the framework of a technical harmonization directive From : Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG) Heinrich-Böll-Ring 10 53119
More informationECOCERT CANADA LABELLING GUIDE. For Canadian Certified Organic Products. Version3
ECOCERT CANADA LABELLING GUIDE For Canadian Certified Organic Products Version3 2014 TABLE OF CONTENTS Validation of label design........3 Use of the Ecocert Trademark....4 Changes to labels.... 4 Prerequisites
More informationOrthoDots CLEAR. Raising the Bar in Quality, Safety, and Compliance. A White Paper By:
OrthoDots CLEAR Raising the Bar in Quality, Safety, and Compliance A White Paper By: Dr. Michael Silver (PhD Chemistry) Dr. Mart McClellan (DDS, MS) Anne Armstrong Ron Schutt May 2018 TABLE OF CONTENTS
More informationFinal Rules Preventive Controls for Human Food Preventive Controls for Animal Food
Final Rules Preventive Controls for Human Food Preventive Controls for Animal Food http://www.fda.gov/fsma THE FUTURE IS NOW 1 Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive
More informationGeneral Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme
asean General Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme Ten Nations One Community www.aseansec.org Association of Southeast Asian Nations General Information Booklet on the
More informationWelcome to this edition of the
MEDICAL DEVICES November 2004 Vol. 1 No. 10 IRISH MS BOARD, EARLSFORT CENTRE, EARLSFORT TERRACE, DUBLIN 2 TEL: 01 676 4971 FAX: 01 676 7836 EMAIL: MEDICALDEVICES@IMB.IE EDITORIAL Letter from the Editor
More informationEU Regulatory Update & GMP Deficiencies. Bryan J Wright July 2017
EU Regulatory Update & GMP Deficiencies Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline Update on changes in EU GMP Guide Summary of GMP changes to the Guide Important details of changes over the
More informationCurriculum Vitae. Lone Cleveland Andersen. Courses
Courses and continuing education, listed by subjects. GMP courses API Curriculum Vitae Lone Cleveland Andersen Courses ICH Q7; Compliance for API s manufactured by cell culturing and fermentation, European
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context
More informationRecall Guidelines. for Chinese Medicine Products
Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st
More informationGeneral Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.
General Chapter/Section: Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. of Commenters: 18 Editorial changes suggested by commenters have been reviewed by
More informationSingle market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,
More informationEC Declaration of Conformity
EC Declaration of Conformity MegaGen Implant Co., Ltd. 377-2, Gyochon-ri, Jain-myeon, Gyeongsan-si, Gyeongbuk, Korea declare that the medical devices described hereafter The Dental Implant Superstructure
More informationOffice No. E E, Amber Gem Tower, SHeikh Khalifa Bin Zayed Road 2, Ajman, U.A.E
IAS Accreditation Number MSCB-119 Company Name AQC MIDDLE EAST F.Z.E Address Office No. E1-1401 E, Amber Gem Tower, SHeikh Khalifa Bin Zayed Road 2, Ajman, U.A.E Contact Name Nadeem Pasha Telephone +971
More information1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán
Risk in Dosimetry. Industry Stand point 1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán Agenda IBA. IBA Dosimetry Risks in Dosimetry Product development Product manufacturing Product
More informationAccredited Certification International Limited. Migration Q&A
Accredited Certification International Limited Migration Q&A ISO 45001:2018 Q&A Page 2 The issue date of ISO 45001:2015: March 2018 The migration period: 30 March 2018 30 March 2021 (3 years) The expiry
More informationFalsified Medicines Directive - Safety Features Update
Falsified Medicines Directive - Safety Features Update Catherine Neary GMP Conference 12 th November 2014 Agenda Background Delegated Act(s) Proposals Under Consideration White List & Black List Next Steps
More informationBacterin International Incorporated Mr. Howard L. Schrayer 600 Cruiser Lane Belgrade, Montana August 18, 2015
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Bacterin International
More informationSEG s Final Draft THE ORGANISATION OF THE ISLAMIC CONFERENCE (OIC) GUIDELINES FOR THE HALAL ACCREDITATION BODY ACCREDITING HALAL CERTIFICATION BODIES
SEG s Final Draft THE ORGANISATION OF THE ISLAMIC CONFERENCE (OIC) GUIDELINES FOR THE HALAL ACCREDITATION BODY ACCREDITING HALAL CERTIFICATION BODIES 16 October 2009 CONTENTS FOREWORD... 1 INTRODUCTION...
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 9 Inspections, Compliance, Enforcement, and Criminal Investigations Phoenix Medical Devices, LLC 9/29/2009 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationForeign Supplier Verification Programs for Importers of Food for Humans and Animals
Foreign Supplier Verification Programs for Importers of Food for Humans and Animals Docket No. FDA-2011-N-0143 Reference 2: FDA, Proposed 21 Code of Federal Regulations, Part 1, Subpart L Foreign Supplier
More information6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES
CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and
More informationProduct Information Sheet
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationROMANIA National Sanitary Veterinary and Food Safety Authority
ROMANIA National Sanitary Veterinary and Food Safety Authority Progress of Classical Swine Fever control; Requirements for approval of a Channeled System for pork meat production in Romania intended for
More informationBACKFLUSH INSTRUMENTS
BACKFLUSH INSTRUMENTS Versatility designed to handle all your surgical backflush needs. About VitreQ VitreQ creates instruments for the ophthalmic society with a special focus on vitreoretinal surgery.
More informationGuidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business
Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses
More informationRoom: 0D Centre Albert Borschette Rue Froissart Brussels, Belgium
EUROPEAN COMMISSION ENVIRONMENT DIRECTORATE-GENERAL Circular Economy and Green Growth Sustainable Chemicals DIRECTORATE-GENERAL INTERNAL MARKET, INDUSTRY, ENTREPRENEURSHIP AND SMES Consumer, Environmental
More informationProduct Information Sheet
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationin the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use
Frequently Asked Questions Q4B: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions The Q4B Expert Working Group developed a set of frequently asked questions to help users
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 15197 First edition 2003-05-01 In vitro diagnostic test systems Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus Systèmes d'essais
More informationProduct Information Sheet RESISTAMYL
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationLead-up to REACH Pre-Registration
Lead-up to REACH Pre-Registration Steptoe REACH Advisory Services -- What, and Who, are covered By James REACH? Searles (and what to do about it) All Attorney Lunch Meeting Jim Searles 26 April 2007 REACH
More informationAnnex. (Draft for Comments)
Annex Announcement on the Matters related to filing and Joint Review & Approval of Active Pharmaceutical Ingredients, Pharmaceutical Excipients and Pharmaceutical Packaging Materials for Drug Products
More informationProduct Information Sheet REZISTA HV
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationISO Process and Standards Under Development. ISO Principles
Inhalation & Nasal Drugs: The Regulatory Landscape ISO Process and Standards Under Development S.C. Nichols 7 1 ISO Principles ISO standards are developed according to the following principles: Consensus
More informationListing of Color Additives Exempt from Certification; Synthetic Iron Oxide
This document is scheduled to be published in the Federal Register on 03/20/2015 and available online at http://federalregister.gov/a/2015-06418, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationProduct Information Sheet REZISTA DF
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationSP MEDIKAL NEWS. of the Helix device as batch monitoring device but also the big advantages when compared to detection possibilities of CI and BI s.
SP MEDIKAL NEWS Third newsletter by SP Medikal San. Ltd In this Edition: After the wintertime the spring and summertime is welcomed by many people. These seasons are giving energy and motivation. After
More informationPublic Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA Telephone: 510/
Department of Health and Human Services Public Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Telephone: 510/337-6700 WARNING LETTER December
More informationChecklist of issues to be considered by food business operators when implementing Commission Regulation (EC) No 2073/2005
Checklist of issues to be considered by food business operators when implementing Commission Regulation 1. General requirements 2. Sampling foodstuffs and testing against the relevant criteria 2.1 Validation
More informationMedical Devices and Active Implantable Medical Devices
Medical Devices and Active Implantable Medical Devices Exclusion Interpretation Guide MD e IAMD ANREEE October 2016 This document aims to clarify in what circumstances certain equipment can be considered
More informationMedication errors. Impact of medication error guidance and regulation on drug-device combination products. June 2017 Dan Wozinski
Medication errors Impact of medication error guidance and regulation on drug-device combination products June 2017 Dan Wozinski Agenda Understand the management of medication errors within global requirements
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893
COUNCIL OF THE EUROPEAN UNION Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DLEG 51 CODEC 893 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: Common Position with
More information